RPG Life Sciences Ltd approves Q2 and H1 FY27 unaudited results and revised Related Party Transactions Policy
- Results cover the quarter and half-year ended 30 September 2026; standalone and consolidated statements were approved.
- Statutory auditors’ limited review reports were considered alongside the results.
- The Board meeting was held on 29 October 2026; financial figures were not included in the announcement.